Importantly, ex vivo analysis of tumor-infiltrating T cells that were identified by their congenic CD45.2 marker expression demonstrated strongly increased effector functions, such as granzyme B and IFN-γ expression, if the mice received T cells that were pretreated under high conditions (Fig. 6e). The gene discussed is IFNG; the disease is neoplasm.